姓名：戴厚永
职称：副教授、主任医师
个人简介：安徽太湖人，医学博士、博士后。
专业研究领域：慢性肾脏病；糖尿病肾病；血液净化及其并发症治疗。
专著与论集：
2. ,,,,,,,.the roles of connective tissue growth factor and integrin-linked kinase in high glucose-induced phenotypic alterations of podocytes. j cell biochem. 2012;113(1):293-301.
3. ,,,, , . inhibition of integrin-linked kinase by angiotensin ii receptor antagonist, irbesartan attenuates podocyte injury in diabetic rats. chin med j (engl). 2012;125(5):888-93.
4. ,,,,.the role of renal damage on cardiac remodeling in patients with diabetic nephropathy. clin nephrol. 2013;80(4):249-55.
5. , , , , , . ctgf mediates high-glucose induced epithelial-mesenchymal transition through activation of β-catenin in podocytes. 2016;38(10):1711-1716.
6., , , , , , . protection of ctgf antibody against diabetic nephropathy in mice via reducing glomerular β-catenin expression and podocyte epithelial-mesenchymal transition. 2017; 118(11):3706-3712.
7. cao y, zhang y, wang x, zhang y, fan y, shi h, dai h. medicine (baltimore). 2018;97(50):e13614.
8. wang x, guo n, chen y, dai h. a new model to predict acute kidney injury after cardiac surgery in patients with renal insufficiency. ren fail. 2022 ;44(1):767-776.
主要科研项目
先后参加4项国家自然科学基金项目研究，主持南通市科技计划项目2项，中华医学会临床科研专项基金1项，获南通市科技进步二等奖2项。
讲授课程
诊断学、内科学肾脏内科部分章节；
指导研究生情况
已毕业硕士生10名，在读硕士生7名。
